Warts and DADA2: a Mere Coincidence?

J Clin Immunol. 2018 Nov;38(8):836-843. doi: 10.1007/s10875-018-0565-0. Epub 2018 Nov 1.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / deficiency*
  • Adenosine Deaminase / genetics
  • Adult
  • Agammaglobulinemia / drug therapy
  • Agammaglobulinemia / genetics*
  • Anti-Inflammatory Agents / therapeutic use
  • Autoimmunity
  • Child
  • Child, Preschool
  • Etanercept / therapeutic use
  • Genotype*
  • Homozygote
  • Humans
  • Inflammation
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Male
  • Mutation / genetics*
  • Pedigree
  • Phenotype
  • Severe Combined Immunodeficiency / drug therapy
  • Severe Combined Immunodeficiency / genetics*
  • Skin / pathology*
  • Warts / drug therapy
  • Warts / genetics*

Substances

  • Anti-Inflammatory Agents
  • Intercellular Signaling Peptides and Proteins
  • ADA2 protein, human
  • Adenosine Deaminase
  • Etanercept

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency